AKT1 and breast carcinoma: It was found that PI3Kδ expression levels negatively correlate with the PTEN activity in breast cancer and PCa, and inhibiting PI3Kδ restores the PTEN activity and inhibits the AKT signaling and subsequently suppresses cell proliferation [23,44,45].